Adaptive deep brain stimulation has virtually eliminated the most debilitating motor symptoms for some Parkinson’s patients ...

Parkinson's is one of the most well known diseases that affects the brain and more specifically, the central nervous system.

It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...

Parkinson's disease overview, treatment options, including deep brain stimulation, and future developments in neurosurgery by ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... patients with moderate to advanced PD with motor fluctuations.

UCB, a global biopharmaceutical company, today announced it will present 8 scientific abstracts, including 3 late-breaker oral presentations, highlighting key data from its innovative ...

Investigators pointed out that people who have advanced Parkinson’s disease and dementia with Lewy bodies pose greater challenges for hospice care providers than others. Their disease course has ...

The second annual Team 81 Ride for Parkinson’s will take place this summer as a 300-kilometre ride across Manitoba to raise money for the cause. Cyclists can take part in the entire ride or specific ...